You EL, Henry M, Zeitouni AG. Human papillomavirus–associated oropharyngeal cancer: review of current evidence and management. Curr Oncol. 2019;26(2):119–23. https://doi.org/10.3747/co.26.4819.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamilton D, Khan MK, O’Hara J, Paleri V. The changing landscape of oropharyngeal cancer management. J Laryngol Otol. 2017;131(1):3–7. https://doi.org/10.1017/s0022215116009178.

Article  CAS  PubMed  Google Scholar 

Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol. 2022;19(5):306–27. https://doi.org/10.1038/s41571-022-00603-7.

Article  PubMed  PubMed Central  Google Scholar 

Kimple RJ, Harari PM. The prognostic value of HPV in head and neck cancer patients undergoing postoperative chemoradiotherapy. Ann Transl Med. 2015:S14.

Zanoni DK, Patel SG, Shah JP. Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: rationale and implications. Curr Oncol Rep. 2019. https://doi.org/10.1007/s11912-019-0799-x.

Article  PubMed  PubMed Central  Google Scholar 

Shaw RJ, Lowe D, Woolgar JA, et al. Extracapsular spread in oral squamous cell carcinoma. Head Neck. 2009. https://doi.org/10.1002/hed.21244.

Article  Google Scholar 

Mermod M, Tolstonog G, Simon C, Monnier Y. Extracapsular spread in head and neck squamous cell carcinoma: a systematic review and meta-analysis. Oral Oncol. 2016;62:60–71. https://doi.org/10.1016/j.oraloncology.2016.10.003.

Article  PubMed  Google Scholar 

Sinha P, Lewis JS, Piccirillo JF, Kallogjeri D, Haughey BH. Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer. 2012;118(14):3519–30. https://doi.org/10.1002/cncr.26671.

Article  CAS  PubMed  Google Scholar 

Ferris RL, Flamand Y, Weinstein GS, et al. Phase II Randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer research group trial (E3311). J Clin Oncol. 2022;40(2):138–49. https://doi.org/10.1200/jco.21.01752.

Article  CAS  PubMed  Google Scholar 

Owadally W, Hurt C, Timmins H, et al. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015;15:602. https://doi.org/10.1186/s12885-015-1598-x.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehanna H, Robinson M, Hartley A, et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet. 2019;393(10166):51–60. https://doi.org/10.1016/s0140-6736(18)32752-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, The PRISMA, et al. statement: an updated guideline for reporting systematic reviews. BMJ. 2020;2021:n71. https://doi.org/10.1136/bmj.n71.

Article  Google Scholar 

Team RC. R: A language and environment for statistical computing. R Foundation for Statistical Computing. https://www.R-project.org/

Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evidence Based Mental Health. 2019;22(4):153–60. https://doi.org/10.1136/ebmental-2019-300117.

Article  PubMed  PubMed Central  Google Scholar 

Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280–6. https://doi.org/10.7326/0003-4819-158-4-201302190-00009.

Article  PubMed  Google Scholar 

Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ. 2016;353:i2016. https://doi.org/10.1136/bmj.i2016.

Article  PubMed  Google Scholar 

Guyatt GH, Oxman AD, Sultan S, et al. GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol. 2011;64(12):1311–6. https://doi.org/10.1016/j.jclinepi.2011.06.004.

Article  PubMed  Google Scholar 

Albergotti WG, Schwarzbach HL, Abberbock S, et al. Defining the prevalence and prognostic value of perineural invasion and angiolymphatic invasion in human papillomavirus-positive oropharyngeal carcinoma. JAMA Otolaryngol Head Neck Surg. 2017;143(12):1236–43. https://doi.org/10.1001/jamaoto.2017.2019.

Article  PubMed  PubMed Central  Google Scholar 

An Y, Park HS, Kelly JR, et al. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. Cancer. 2017;123(14):2762–72. https://doi.org/10.1002/cncr.30598.

Article  CAS  PubMed  Google Scholar 

Bauer E, Mazul A, Chernock R, et al. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma. Laryngoscope. 2020;130(4):939–45. https://doi.org/10.1002/lary.28059.

Article  CAS  PubMed  Google Scholar 

Bu DD, Ferrandino R, Robinson EM, et al. Lymph node ratio in HPV-associated oropharyngeal cancer: identification of a prognostic threshold. Laryngoscope. 2021;131(1):E184-e189. https://doi.org/10.1002/lary.28689.

Article  PubMed  Google Scholar 

Chen SY, Last A, Ettyreddy A, et al. 20 pack-year smoking history as strongest smoking metric predictive of HPV-positive oropharyngeal cancer outcomes. Am J Otolaryngol. 2021;42(3):102915. https://doi.org/10.1016/j.amjoto.2021.102915.

Article  PubMed  PubMed Central  Google Scholar 

Choi KH, Song JH, Hong JH, et al. Importance of lymph node ratio in HPV-related oropharyngeal cancer patients treated with surgery and adjuvant treatment. PLoS ONE. 2022;17(8):e0273059. https://doi.org/10.1371/journal.pone.0273059.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cramer JD, Dundar Y, Hotaling J, Raza SN, Lin H-S. Development and assessment of a novel composite pathologic risk stratification for surgically resected human papillomavirus–associated oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2019;145(12):1105. https://doi.org/10.1001/jamaoto.2019.0820.

Article  PubMed  PubMed Central  Google Scholar 

Day AT, Yang AM, Tanamal P, et al. Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: national hospital-based retrospective cohort analysis. Head Neck. 2021;43(11):3345–63. https://doi.org/10.1002/hed.26825.

Article  PubMed  Google Scholar 

El Asmar M, Tsai HL, Fakhry C, et al. The prognostic impact of pathologic lymph nodes in HPV-positive oropharyngeal cancers. Oral Oncol. 2019;89:23–9. https://doi.org/10.1016/j.oraloncology.2018.12.005.

Article  PubMed  Google Scholar 

Faraji F, Fung N, Zaidi M, et al. Tumor-infiltrating lymphocyte quantification stratifies early-stage human papillomavirus oropharynx cancer prognosis. Laryngoscope. 2020;130(4):930–8. https://doi.org/10.1002/lary.28044.

Article  CAS  PubMed  Google Scholar 

Freitag J, Wald T, Kuhnt T, et al. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma. Cancer. 2020;126(9):1856–72. https://doi.org/10.1002/cncr.32667.

Article  CAS  PubMed  Google Scholar 

Gay H, Liu J, Spencer C, et al. Outcomes of P16 positive oropharyngeal squamous cell carcinoma treated with surgery and adjuvant IMRT. J Radiat Oncol. 2014;4:37–46. https://doi.org/10.1007/s13566-014-0170-7.

Article  CAS  Google Scholar 

Gomez ED, Chang JC, Ceremsak JJ, et al. Impact of lymph node yield on survival in surgically treated oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg. 2021;164(1):146–56. https://doi.org/10.1177/0194599820936637.

Article  PubMed  Google Scholar